Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation (vol 71, pg 237, 2011)

被引：0
|
作者：
Atar, D. [1 ]
Banach, M. [2 ]
Ehrlich, J. R. [3 ]
Fedida, D. [4 ,5 ]
Lip, G. Y. H. [6 ]
Savelieva, I. [7 ]
机构：
[1] Univ Oslo, Div Cardiol, Oslo, Norway
[2] Med Univ Lodz, Dept Hypertens, Lodz, Poland
[3] Goethe Univ Frankfurt, Div Cardiol, Frankfurt, Germany
[4] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada
[6] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
[7] St Georges Univ London, Div Cardiac & Vasc Sci, London, England
来源：
DRUGS | 2011年 / 71卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: A meta-analysis
    Akel, Tamer
    Lafferty, James
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2018, 23 (03)
  • [22] Recent-Onset Atrial Fibrillation in Patients With Left Ventricular Dysfunction: Amiodarone or Vernakalant?
    Conde, Diego
    Costabel, Juan Pablo
    de Lima, Alberto Alves
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10)
  • [23] Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study
    Bager, Johan-Emil
    Martin, Alfonso
    Dalmau, Jose Carbajosa
    Simon, Alexander
    Merino, Jose L.
    Ritz, Beate
    Hartikainen, Juha E. K.
    CARDIOLOGY, 2022, 147 (5-6) : 566 - 577
  • [24] Intravenous amiodarone in treatment of recent-onset atrial fibrillation
    Lip, GYH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (04) : 1080 - 1081
  • [25] Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation
    Cybulski, J
    Kulakowski, P
    Budaj, A
    Danielewicz, H
    Maciejewicz, J
    Kawka-Urbanek, T
    Ceremuzynski, L
    CLINICAL CARDIOLOGY, 2003, 26 (07) : 329 - 335
  • [26] MANAGEMENT OF RECENT-ONSET ATRIAL-FIBRILLATION
    HEULIN, A
    VACHERON, A
    SEMAINE DES HOPITAUX, 1991, 67 (40-41): : 1803 - 1805
  • [27] Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study
    Samuel Lévy
    Juha Hartikainen
    Beate Ritz
    Tord Juhlin
    José Carbajosa-Dalmau
    Hans Domanovits
    Cardiovascular Drugs and Therapy, 2021, 35 : 283 - 292
  • [28] Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department (vol 27, pg 38, 2011)
    Stiell
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (02) : 244 - 244
  • [29] Vernakalant Hydrochloride: A Novel Atrial-selective Agent for the Cardioversion of Recent-onset Atrial Fibrillation in the Emergency Department (vol 17, pg 1175, 2010)
    Stiell
    ACADEMIC EMERGENCY MEDICINE, 2011, 18 (02) : 224 - 224
  • [30] Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study
    Levy, Samuel
    Hartikainen, Juha
    Ritz, Beate
    Juhlin, Tord
    Carbajosa-Dalmau, Jose
    Domanovits, Hans
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (02) : 283 - 292
12345